A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia

Código QR

A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia

Objectives. The aim of this study was to provide the first study to systematically analyze the efficacy and safety of PCSK9-mAbs in the treatment of familial hypercholesterolemia (FH). Methods. A computer was used to search the electronic Cochrane Library, PubMed/MEDLINE, and Embase databases for cl...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xiaoyue Ge, Tiantian Zhu, Hao Zeng, Xin Yu, Juan Li, Shanshan Xie, Jinjin Wan, Huiyao Yang, Keke Huang, Weifang Zhang
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/e51a44835611488ab7f48d477e25e3ac
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players
por: Patrice Marques, et al.
Publicado: (2022)

Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
por: Li Jun Qian, et al.
Publicado: (2017)

PROPORTION OF PSORIASIS IN FAMILIAL HYPERCHOLESTEROLEMIA
por: Samip Sheth, et al.
Publicado: (2021)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma S, et al.
Publicado: (2019)

The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population
por: R. H. Fairoozy, et al.
Publicado: (2017)

Erratum: Genetic testing for familial hypercholesterolemia—past, present, and future
por: Marta Futema, et al.
Publicado: (2021)

A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects
por: Liu C, et al.
Publicado: (2019)

Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia
por: Xia Pu, et al.
Publicado: (2021)

Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
por: Khalid F Alhabib, et al.
Publicado: (2021)

Complex Phenotype of Hypercholesterolemia in a Family with Both ABCG8 and APOB Mutations
por: Ana Cristina Ferreira, et al.
Publicado: (2021)

Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated.
por: Trond P Leren, et al.
Publicado: (2011)

Apolipoprotein B gene mutation related to familial hypercholesterolemia in an Iranian population: With or without hypothyroidism
por: Golnaz Vaseghi, et al.
Publicado: (2021)

Efficacy and safety of therapeutic plasma exchange in stiff person syndrome
por: Czempik Piotr F., et al.
Publicado: (2021)

Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
por: Antonio Gallo, et al.
Publicado: (2021)

Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
por: Sadik H Kassim, et al.
Publicado: (2010)

Effects of Evolocumab Added to Moderate-Intensity Statin Therapy in Chinese Patients With Acute Coronary Syndrome: The EMSIACS Trial Study Protocol
por: Jing Gao, et al.
Publicado: (2021)

A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data
por: Rana K, et al.
Publicado: (2019)

Genetic basis of hypercholesterolemia in adults
por: Seyedmohammad Saadatagah, et al.
Publicado: (2021)

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
por: Elisenda Climent, et al.
Publicado: (2017)

Analysis of Rare Variants in Genes Related to Lipid Metabolism in Patients with Familial Hypercholesterolemia in Western Siberia (Russia)
por: Elena Shakhtshneider, et al.
Publicado: (2021)

IMPROVING PRIMARY CARE AWARENESS AND SCREENING OF ADULTS WITH FAMILIAL HYPERCHOLESTEROLEMIA THROUGH AN ONLINE PROVIDER EDUCATIONAL PROGRAM
por: Mary Nametka, et al.
Publicado: (2021)

Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin
por: Wang Z, et al.
Publicado: (2013)

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Hirotaka Fukami, et al.
Publicado: (2021)

Critical left main coronary artery stenosis in a patient with homozygous familial hypercholesterolemia and aortic valve replacement
por: Nuri Köse, et al.
Publicado: (2021)

Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
por: Ji Bak Kim, et al.
Publicado: (2021)

Author Correction: Genetic basis of hypercholesterolemia in adults
por: Seyedmohammad Saadatagah, et al.
Publicado: (2021)

Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study.
por: Jean Ferrières, et al.
Publicado: (2021)

Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Shanshan Lin, et al.
Publicado: (2021)

Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.
por: Roeland Huijgen, et al.
Publicado: (2010)

Data mining: traditional spring festival associated with hypercholesterolemia
por: Danchen Wang, et al.
Publicado: (2021)

Family Safety & Health

The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
por: Kacar M, et al.
Publicado: (2020)

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
por: Bassiony S, et al.
Publicado: (2020)

Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature
por: Bárbara Fuenzalida, et al.
Publicado: (2018)

The Sensimed Triggerfish contact lens sensor: efficacy, safety, and patient perspectives
por: Dunbar GE, et al.
Publicado: (2017)

Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan SX, et al.
Publicado: (2018)

The safety and efficacy of xanthan gum-based thickeners and their effect in modifying bolus rheology in the therapeutic medical management of dysphagia
por: Enrico K. Hadde, et al.
Publicado: (2021)

Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan S, et al.
Publicado: (2017)

The Safety and Efficacy of Weighted Baseballs
por: Michael M Reinold, et al.
Publicado: (2021)

Glibenclamide - profile of efficacy and safety
por: Lyudmila Viktorovna Nedosugova
Publicado: (2011)